Bill Sponsor
Senate Bill 3630
116th Congress(2019-2020)
Facilitating Innovation to Fight Coronavirus Act
Introduced
Introduced
Introduced in Senate on May 6, 2020
Overview
Text
Sponsor
Introduced
May 6, 2020
Latest Action
May 6, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3630
Congress
116
Policy Area
Law
Law
Primary focus of measure is matters affecting civil actions and administrative remedies, courts and judicial administration, general constitutional issues, dispute resolution, including mediation and arbitration. Measures concerning specific constitutional amendments may fall under the policy area relevant to the subject matter of the amendment (e.g., Education). Measures concerning criminal procedure and law enforcement may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Nebraska
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Facilitating Innovation to Fight Coronavirus Act

This bill provides immunity from civil liability to health care providers for certain actions taken during the COVID-19 (i.e., coronavirus disease 2019) public health emergency and lengthens the terms of certain medical patents related to the treatment of COVID-19.

Specifically, when testing for or treating COVID-19 during the public health emergency, a health care provider may not be held liable in any federal, state, or local civil proceeding for (1) using or modifying a medical device for an unapproved use or indication; (2) practicing without a license or outside of an area of specialty, if instructed to do so by an individual with such a license or within such an area of speciality; or (3) conducting the testing of, or providing treatment to, a patient outside of the premises of standard health care facilities.

Additionally, certain medical patents that are issued with respect to the treatment of COVID-19 are deemed not to begin until the termination of the presidential emergency declaration relating to COVID-19 and are extended for an additional 10 years.

Text (1)
Actions (2)
05/06/2020
Read twice and referred to the Committee on the Judiciary.
05/06/2020
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:42:44 PM